Posted on 5/1/18
Edge Therapeutics Reports First Quarter 2018 Financial Results
BERKELEY HEIGHTS, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced financial results for the quarter ended March 31, 2018.First Quarter Financial . . .
Posted on 5/1/18
Edge Therapeutics Announces Review of Strategic Alternatives
BERKELEY HEIGHTS, N.J., April 30, 2018 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq:EDGE) today announced that its Board of Directors is conducting a comprehensive review of . . .
Posted on 5/1/18
Spark Therapeutics Sells Priority Review Voucher for $110 Million
PHILADELPHIA, April 30, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, today announced . . .
Posted on 5/1/18
Tabula Rasa HealthCare Subsidiary CareKinesis Signs Agreement with SpiriTrust Lutheran LIFE
MOORESTOWN, N.J., April 30, 2018 (GLOBE NEWSWIRE) -- CareKinesis, a subsidiary of Tabula Rasa HealthCare (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, . . .
Posted on 4/30/18
Spark Therapeutics Sells Priority Review Voucher for $110 Million
Spark Therapeutics (NASDAQ:ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease
Posted on 4/30/18
What to Expect with Pfizer's Q1 Results
Pfizer (NYSE:PFE) stock hasn't been a big winner so far in 2018. On the other hand, the big pharma stock is beating the S&P 500 index . . .
Posted on 4/29/18
Blink Fitness Opens Its Newest New Jersey Location In Newark
Blink Fitness, the premium-quality, value-based fitness club, is excited to announce the grand opening of its 69th location, in Newark. The club will open the doors . . .
Posted on 4/29/18
Amneal And Impax Receive FTC Clearance For Business Combination
Amneal Pharmaceuticals LLC and Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the U.S. Federal Trade Commission (FTC) has cleared the Amneal and Impax business combination, . . .
Posted on 4/29/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on April 24, 2018 it approved non-statutory stock options to purchase an aggregate of 172,150 shares of its . . .
Posted on 4/27/18
Onconova Therapeutics Prices $25.0M Upsized Underwritten Public Offering
NEWTOWN, Pa., April 27, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug . . .
Posted on 4/27/18
Teligent Announces Agreements to Exchange Approximately $65 million of its Senior Convertible Notes
BUENA, N.J., April 27, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT) announced today that it has entered into separate, privately negotiated exchange agreements with certain holders . . .
Posted on 4/27/18
Better Buy: Celgene Corporation vs. Gilead Sciences
You would have done quite well to buy and hold shares of either Celgene Corporation(NASDAQ:CELG) or Gilead Sciences (NASDAQ:GILD) over the past decade. Both soared more . . .
Posted on 4/27/18
Fujirebio Enters into Agreement with Janssen Pharmaceuticals
MALVERN, Pa.--(BUSINESS WIRE)--Fujirebio Inc., a consolidated subsidiary of Miraca Holdings Inc., (Head office: Shinjuku-ku, Tokyo, President and CEO: Yoshihiro Ashihara, hereinafter “Fujirebio” or “the Company”) announced . . .
Posted on 4/27/18
Palmyra Nursing Homes Awarded Five-Stars by Centers for Medicare and Medicaid
The Gardens at Palmyra and The Gardens at Campbelltown, both located in Palmyra, PA, attained The Centers for Medicare and Medicaid Services overall rating of five . . .
Posted on 4/26/18
Johnson & Johnson Prevails in Appeal of $151M Judgement in Hip Implant Case; Shares Up 2%
An appellate court has overturned a $151M award to five people allegedly harmed by hip implants made by Johnson & Johnson (JNJ +1.7%).The three-judge panel found . . .
Posted on 4/26/18
Halifax-Backed Delphi Behavioral Health Group Merges With Summit Behavioral Health
Delphi Behavioral Health Group, a leading substance abuse treatment provider, announced today it has merged with Summit Behavioral Health to expand its service
Posted on 4/25/18
The Vitamin Shoppe Recognized With 2018 StellaService Elite Overall Award For Exceptional Customer Service
The Vitamin Shoppe®, an omni-channel specialty retailer and contract manufacturer of nutritional products, today announced that StellaService, an independent company that measures the customer service performance . . .
Posted on 4/25/18
Better Buy: Amgen Inc. vs. Celgene
It's indisputable.Amgen (NASDAQ:AMGN) has been the hands-down winner over Celgene (NASDAQ:CELG) in terms of stock performance over the last year. It's the same story for revenue . . .
Posted on 4/24/18
Children's Hospital of Philadelphia Announces Expansion of Multi-Partner Medical Legal Partnership
Children's Hospital of Philadelphia (CHOP) today announced the expansion of its Multi-Partner Medical Legal Partnership (MLP), a collaboration between the Hospital and the University of Pennsylvania . . .
Posted on 4/24/18
Continuum Health Selected to Support Riverside Medical Group's N.J. Expansion
One of New Jersey's fastest-growing medical groups has chosen Continuum Health to support its expansion throughout the state.Secaucus-based Riverside Medical Group (RMG) marks its entry into . . .
Posted on 4/24/18
Valeritas Prices $24 Million Public Offering of Common Stock
BRIDGEWATER, N.J., April 24, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company which offers patients with type 2 diabetes V-Go® Wearable Insulin . . .
Posted on 4/24/18
Celgene: Will Tremfya Punish Otezla Too?
[Editor's note: An earlier version of this article referenced Pfizer's Xeljanz in relation to psoriasis. However, Xeljanz only treats psoriatic arthritis. This has been corrected.]Johnson & . . .
Posted on 4/24/18
Celgene: Bold Pursuits In Science With 24.66% Discount
Celgene Corporation (NASDAQ:CELG) is one of the most appealing stocks for value investors within the pharmaceuticals sector because of its good value with a proven track . . .
Posted on 4/24/18
Johnson & Johnson's Top-Line Growth Isn't What It Seems
Johnson & Johnson (NYSE:JNJ) recently reported that its revenue soared 12.6% to $20 billion in the first quarter. However, that revenue growth rate comes with an . . .
Posted on 4/23/18
Mountainside Medical Group Adds New Physicians
MONTCLAIR, N.J.--(BUSINESS WIRE)--Mountainside Medical Group announced today the addition of three new physicians, Pulmonologist Juhayna Davis, M.D., Endocrinologist Anjali Grover, M.D., andOB/GYNspecialist Vanessa Parisi, D.O., expanding . . .

